GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Evolent Health Inc (STU:9EH) » Definitions » EBITDA Margin %

Evolent Health (STU:9EH) EBITDA Margin % : 1.92% (As of Sep. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Evolent Health EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Evolent Health's EBITDA for the three months ended in Sep. 2024 was €11 Mil. Evolent Health's Revenue for the three months ended in Sep. 2024 was €560 Mil. Therefore, Evolent Health's EBITDA margin for the quarter that ended in Sep. 2024 was 1.92%.


Evolent Health EBITDA Margin % Historical Data

The historical data trend for Evolent Health's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evolent Health EBITDA Margin % Chart

Evolent Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -37.04 -26.04 6.13 1.53 -1.26

Evolent Health Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.16 -1.12 2.94 5.75 1.92

Competitive Comparison of Evolent Health's EBITDA Margin %

For the Health Information Services subindustry, Evolent Health's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Evolent Health's EBITDA Margin % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Evolent Health's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Evolent Health's EBITDA Margin % falls into.



Evolent Health EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Evolent Health's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-22.728/1800.893
=-1.26 %

Evolent Health's EBITDA Margin % for the quarter that ended in Sep. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Sep. 2024 )/Revenue (Q: Sep. 2024 )
=10.771/559.882
=1.92 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Evolent Health  (STU:9EH) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Evolent Health EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Evolent Health's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Evolent Health Business Description

Traded in Other Exchanges
Address
1812 N. Moore Street, Suite 1705, Arlington, VA, USA, 22209
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The primary solutions provided by the company include specialty care management services, total cost of care management, and administrative services.

Evolent Health Headlines

No Headlines